pandem
led
widespread
shortag
person
protect
equip
ppe
healthcar
worker
includ
filter
facepiec
respir
ffr
mask
mask
normal
intend
singl
use
steril
subsequ
reus
could
substanti
mitig
worldwid
shortag
studi
investig
ppe
steril
use
ioniz
hydrogen
peroxid
ihp
gener
steramist
equip
tomi
frederick
md
seal
environ
chamber
instal
anim
facil
academ
medic
center
follow
one
five
steril
cycl
five
mask
model
three
manufactur
evalu
use
three
criteria
effici
ihp
steril
measur
bacteri
spore
standard
biolog
indic
assembl
abil
steril
mask
effici
filter
particl
quantit
fit
test
filtrat
effici
measur
use
ambient
particul
matter
univers
lab
aerosol
nacl
challeng
nation
institut
occup
safeti
health
niosh
precertif
laboratori
data
demonstr
mask
steril
use
steramist
ihp
technolog
retain
function
five
cycl
maximum
number
test
ppe
could
also
steril
manner
pretreat
handheld
ihp
gener
requir
semienclos
surfac
respir
hose
typic
environ
chamber
volum
treat
mask
per
day
well
item
ppe
make
effect
approach
busi
medic
center
pandem
led
widespread
shortag
person
protect
equip
ppe
clinician
first
respond
shortag
filter
facepiec
respir
ffr
mask
certifi
filter
airborn
particl
particularli
problemat
normal
singleus
item
mainstay
infect
control
wide
report
us
depart
health
human
servic
hh
anticip
need
mani
x
mask
us
use
alon
estim
total
avail
suppli
far
short
number
consequ
need
mask
steril
subsequ
reus
therefor
like
continu
forese
futur
possibl
dispos
mask
could
steril
reus
rais
year
ago
strategi
address
shortag
aris
medic
emerg
except
singl
fdafund
studi
battel
memori
institut
littl
subsequ
research
perform
topic
recent
respons
acut
mask
shortag
multipl
strategi
mask
steril
propos
studi
includ
exposur
ultraviolet
uv
germicid
irradi
vapor
hydrogen
peroxid
moist
heat
ethylen
oxid
gamma
irradi
studi
evalu
recent
develop
technolog
ioniz
hydrogen
peroxid
ihp
method
steriliz
mask
ppe
hydrogen
peroxid
h
power
steril
agent
use
porou
surfac
follow
vapor
ioniz
creat
mist
contain
hydroxyl
radic
vapor
ioniz
hydrogen
peroxid
method
vhpihp
wide
use
environment
steril
across
multipl
industri
includ
food
prepar
healthcar
life
scienc
vhpihp
method
use
wider
rang
sensit
materi
high
temperatur
method
eg
autoclav
safer
ethylen
oxid
method
four
distinct
vhpihpbas
h
steril
technolog
commerci
date
shown
tabl
involv
differ
approach
gener
deliv
steril
case
microbi
kill
achiev
reaction
hydroxyl
radic
protein
nucleic
acid
biomolecul
pathogen
three
vhpbase
system
receiv
emerg
use
author
eua
food
drug
administr
fda
mask
decontamin
even
though
rel
limit
peerreview
data
avail
particularli
noncommerci
third
parti
consequ
difficult
infect
control
team
hospit
healthcar
provid
evalu
system
absenc
data
poststeril
perform
differ
make
model
mask
also
limit
brigham
women
hospit
bwh
boston
incid
command
involv
studi
current
hand
model
mask
three
manufactur
topic
studi
current
investig
steril
ppe
reus
academ
medic
center
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
studi
focus
use
ihp
tm
mask
steril
method
specif
steramist
binari
ioniz
technolog
bit
tomi
beverli
hill
ca
ihp
regist
environment
protect
agenc
epa
use
health
care
life
scienc
food
safeti
set
appear
epa
list
g
h
k
l
recent
ad
epa
list
n
disinfect
use
use
hard
nonpor
surfac
activ
ingredi
ihp
aqueou
h
h
concentr
time
lower
use
commerci
vhp
system
flow
past
plasma
arc
dispers
treatment
chamber
mist
microns
liquid
droplet
pass
plasma
hydrogen
peroxid
ioniz
reactiv
hydroxyl
radic
activ
steril
ihp
commerci
avail
two
implement
handheld
sprayer
devic
surfac
unit
environment
unit
environ
system
environ
system
use
studi
instal
dana
farber
cancer
institut
dfci
boston
anim
research
facil
use
steril
incom
equip
materi
follow
cycl
steril
mask
test
three
critic
featur
steril
measur
inactiv
bacteri
spore
contain
biolog
indic
filtrat
effici
measur
aerosol
nm
nacl
particl
ambient
particul
matter
fit
use
portacount
quantit
fit
test
apparatu
multipl
steril
cycl
complet
assess
mask
durabl
steril
ppe
item
face
shield
hood
hose
poweredair
purifi
respir
papr
also
explor
test
perform
dfci
mit
ic
laboratori
commerci
laboratori
accredit
perform
test
nioshisoiec
standard
figur
ipad
appl
cupertino
ca
ipad
case
ipad
includ
test
sinc
bwh
make
avail
patient
mean
commun
famili
member
first
set
mask
repres
five
differ
model
process
use
steramist
system
zero
five
cycl
analyz
singlepass
filtrat
effici
use
ambient
particul
matter
mit
second
set
mask
process
use
steramist
system
sent
ic
laboratori
brunswick
oh
test
nioshisoiec
standard
four
mask
underw
quantit
fit
test
dfci
follow
steril
steril
mask
ppe
accomplish
use
steramistequip
room
dimens
x
x
dfci
anim
research
facil
three
steramist
environment
unit
room
version
mount
ceil
room
control
via
singl
panel
access
outsid
ihp
mist
deliv
three
nozzl
total
mlmin
min
yield
deliv
concentr
mlm
mask
place
interior
surfac
face
standard
stainlesssteel
shelv
open
grid
intermetro
style
ppe
also
laid
shelv
except
two
papr
hood
one
papr
hose
tyvek
coveral
hung
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
variou
configur
figur
ppe
space
cm
cm
apart
shelf
design
test
steril
perform
multipl
point
room
presum
tighter
space
could
use
set
two
papr
hood
one
papr
hose
one
face
shield
pretreat
steramist
handheld
spray
devic
advanc
process
steramistequip
chamber
pretreat
intend
ensur
deliveri
steril
item
semienclos
surfac
insid
papr
hose
treat
handheld
devic
consist
spray
equip
distanc
approxim
second
per
surfac
per
manufactur
protocol
steril
cycl
environment
chamber
includ
initi
fill
phase
mist
releas
dwell
phase
allow
mist
penetr
room
scrub
phase
exhaust
reopen
aerat
space
rate
air
chang
per
hour
room
test
quarterli
ensur
homogen
steril
throughout
space
effici
steril
evalu
use
apex
biolog
indic
bi
mesa
lab
boseman
mt
bacteri
spore
indic
resist
kill
virus
therefor
provid
conserv
simpl
estim
steril
effici
particular
geobacillu
stearothermophilu
spore
use
studi
known
difficult
kill
use
hydrogen
peroxid
apex
biolog
indic
ribbon
carri
minimum
x
g
stearothermophilu
spore
bi
posit
prior
first
steril
cycl
mask
bi
place
adjac
mask
papr
compon
equip
bi
place
surfac
judg
least
access
steril
exampl
insid
papr
tube
tabl
bi
extract
use
steril
forcep
place
releasat
growth
medium
mesa
lab
incub
monitor
bacteri
growth
use
colorimetr
assay
period
day
previou
work
g
stearothermophilu
spore
suggest
conserv
benchmark
complet
steril
repres
kill
ratio
number
surviv
initi
viabl
spore
bi
ref
correspond
observ
bacteri
growth
thu
color
chang
day
releasat
medium
singlepass
filtrat
effici
test
perform
mit
four
control
mask
mask
steril
steramistequip
chamber
x
sampl
mask
insert
special
air
duct
supplementari
figur
ambient
particul
matter
driven
duct
thu
mask
fabric
use
pressur
differenti
pascal
ms
face
veloc
concentr
diamet
particl
prior
passag
mask
fabric
determin
use
aerotrak
optic
particl
counter
tsi
inc
shoreview
mn
tabl
although
readili
avail
potenti
effect
test
method
equival
nioshapprov
test
techniqu
mask
thu
result
interpret
rel
absolut
measur
filtrat
effici
second
sampl
steril
mask
test
instantan
filter
effici
ic
lab
niosh
standard
per
niosh
test
procedur
rev
mask
challeng
sodium
chlorid
aerosol
neutral
boltzmann
equilibrium
state
rel
humid
particl
size
distribut
verifi
correspond
median
diamet
geometr
standard
deviat
mask
condit
rel
humid
hour
prior
filter
effici
test
mask
assembl
fixtur
subject
instantan
aerosol
load
load
perform
deposit
sodium
chlorid
aerosol
airflow
rate
liter
per
minut
lpm
one
minut
four
mask
underw
quantit
fit
test
follow
steril
confirm
steril
interfer
abil
mask
form
effect
seal
human
face
test
perform
use
portacount
pro
fit
tester
tsi
inc
shoreview
mn
set
fit
factor
rang
per
manufactur
recommend
ambient
particul
matter
filtrat
data
mask
five
steramist
steril
cycl
mask
test
univers
laboratori
filtrat
effici
three
particl
size
two
mask
test
two
cycl
show
similar
filtrat
effici
one
mask
shown
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
bi
place
adjac
mask
expos
singl
steril
cycl
steramistequip
chamber
exhibit
least
kill
repres
color
chang
follow
seven
day
incub
releasat
medium
bi
place
within
papr
hood
also
achiev
kill
bi
place
papr
hose
pretreat
use
steramist
handheld
spray
devic
supplementari
tabl
bi
place
ipad
ipad
case
panfab
face
shield
tabl
result
obtain
univers
laboratori
singlepass
filtrat
effici
ambient
particl
matter
row
repres
singl
mask
design
pass
steril
threshold
ipad
observ
fulli
function
one
cycl
ihp
treatment
contrast
two
bi
place
insid
either
end
papr
hose
subject
pretreat
steril
determin
rapid
bacteri
growth
follow
transfer
releasat
medium
also
true
bi
embed
thick
foam
top
fisherbrand
dispos
face
shield
test
effect
pretreat
face
shield
handheld
steramist
devic
insert
new
bi
observ
kill
also
fail
threshold
convent
use
score
success
steril
data
conclud
singl
ihp
cycl
effici
steril
mask
equip
place
throughout
steramistequip
decontamin
chamber
process
obvious
damag
delic
equip
ipad
n
penetr
semienclos
space
papr
hose
appear
less
effici
equip
could
steril
pretreat
handheld
ihpdeliveri
devic
follow
cycl
ihp
treatment
chamber
even
pretreat
steril
achiev
thick
face
shield
foam
suggest
normal
dispos
ppe
reus
contrast
customfabr
face
shield
introduc
exist
fda
eua
consist
print
part
appear
steril
effect
perform
data
collect
mit
five
model
mask
three
manufactur
total
unit
use
ambient
particul
matter
filtrat
effici
test
rel
control
mask
observ
reduct
filtrat
effici
particl
mask
subject
five
steril
cycl
tabl
data
pressur
temperatur
air
face
veloc
rel
humid
test
found
supplementari
tabl
figur
show
typic
result
mask
five
steril
cycl
control
mask
steril
data
obtain
across
three
differ
particl
size
mask
total
two
mask
two
cycl
one
mask
zero
one
three
four
five
cycl
respect
four
model
mask
three
manufactur
unit
total
evalu
use
nioshapprov
test
procedur
ic
laboratori
data
show
mask
subject
maximum
five
steril
cycl
retain
filtrat
effici
pass
niosh
test
threshold
tabl
supplementari
tabl
among
mask
test
filtrat
nacl
particl
least
effect
gerson
mask
even
unit
pass
certif
threshold
follow
two
steril
cycl
maximum
number
cycl
test
ic
model
find
suggest
filtrat
effici
sever
model
mask
substanti
affect
one
five
steril
cycl
steril
mask
perform
requir
instantan
filter
effici
test
certif
niosh
standard
see
discuss
test
current
underway
cycl
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
four
mask
test
fit
halyard
use
portacount
equip
pass
read
fit
factor
follow
decontamin
cycl
correspond
filtrat
effici
higher
data
shown
accord
manufactur
guidelin
thu
ihp
steril
appear
impair
abil
mask
form
effect
seal
user
face
hydrogen
peroxid
long
histori
success
use
field
medic
devic
steril
result
support
use
ihp
ppe
steril
deliv
use
steramistequip
environ
chamber
case
complement
pretreat
handheld
ihp
deliveri
devic
extend
ppe
mask
usual
dispos
singl
use
dfci
steramist
environ
chamber
use
studi
volum
could
comfort
fit
mask
per
cycl
without
mask
touch
lesser
number
papr
hood
ppe
rate
assum
ideal
staf
logist
roughli
mask
could
steril
use
per
day
given
typic
minut
steril
cycl
number
could
increas
addit
overnight
workforc
note
studi
keep
standard
practic
steril
judg
use
biolog
indic
contain
bacteri
spore
base
kill
pathogen
encount
clinic
set
howev
g
stearothermophilu
spore
bi
use
studi
known
resist
kill
hydrogen
peroxid
gener
spore
substanti
resist
steril
envelop
virus
recent
work
also
demonstr
vhp
kill
thu
believ
use
bi
rather
assay
viru
load
repres
signific
limit
interpret
data
two
independ
line
evid
one
gener
univers
laboratori
one
commerci
laboratori
accredit
perform
mask
certif
nioshisoiec
standard
show
mask
decontamin
ihp
use
steramist
technolog
retain
perform
respect
filtrat
five
cycl
quantit
fit
test
limit
number
steril
mask
confirm
still
fit
correctli
thu
steril
mask
remain
fulli
function
given
urgenc
mask
shortag
report
result
obtain
date
howev
multipl
addit
test
current
underway
increas
confid
specif
find
practic
steril
reus
mask
gener
exampl
report
data
instantan
filter
effici
test
mask
still
await
result
ic
lab
fulli
load
filtrat
test
requir
compon
test
niosh
standard
quantit
fit
test
mask
model
also
ongo
filtrat
effici
test
decontamin
mask
store
day
treatment
intend
test
timedepend
degrad
mask
perform
follow
steril
test
describ
studi
conduct
use
unus
mask
yet
data
mask
use
actual
health
care
facil
respond
tabl
result
ic
laboratori
filtrat
effici
accord
niosh
standard
procedur
row
repres
data
mask
data
report
averag
test
perform
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
pandem
among
question
address
realworld
test
breath
resist
mask
load
intern
extern
contamin
comfort
level
health
care
worker
use
mask
steril
previous
use
anoth
individu
rate
wastag
aris
breakag
elast
band
contamin
makeup
topic
face
product
unaccept
degrad
fit
remark
type
realworld
use
data
avail
ihpvhpbas
steril
method
even
technolog
heavili
promot
commerci
nonetheless
data
report
studi
judg
clinic
team
suffici
implement
mask
steril
reus
dfci
futur
work
address
question
whether
decontamin
mask
must
return
origin
user
specifi
sterrad
sterri
eua
mask
decontamin
return
common
pool
specifi
batel
eua
latter
substanti
easier
implement
logist
perspect
final
good
support
use
sporebas
bi
measur
effici
steril
direct
test
may
warrant
particularli
case
item
hose
ppe
complex
shape
would
requir
studi
data
support
use
steramist
ihp
technolog
steril
method
reus
mask
includ
mani
commonli
use
model
well
type
ppe
case
follow
pretreat
ihp
handheld
deliveri
devic
interpret
data
import
note
ihpvhp
method
bioquel
approv
fda
eua
cycl
mask
steril
use
altern
hpgp
method
commerci
sterrad
fail
five
cycl
sterrad
eua
approv
steril
cycl
requir
mask
return
singl
user
moreov
data
show
semienclos
item
ppe
papr
hose
steril
without
pretreat
face
shield
thick
foam
may
steril
even
ihp
pretreat
follow
ihp
treatment
environment
chamber
thu
imper
institut
seek
deploy
ihpvhp
technolog
review
avail
primari
data
prior
local
deploy
also
suggest
bi
routin
deploy
attempt
steril
hose
semienclos
pe
compon
issu
describ
steril
mask
recogn
two
decad
base
multipl
instanc
human
transmiss
novel
respiratori
diseas
despit
warn
first
month
global
pandem
demonstr
ineffect
prepar
hope
studi
steril
technolog
ihpvhp
continu
involv
peerreview
independ
acquir
data
better
posit
come
wave
crisi
futur
local
citizen
engin
gener
donat
time
resourc
panfab
essenti
program
success
work
support
harvardmit
center
regulatori
scienc
nihnci
grant
pk
nl
dp
dp
harvard
ludwig
center
akc
support
hugh
hampton
young
fellowship
mit
pk
member
sab
board
director
appli
biomath
glenco
softwar
rarecyt
inc
equiti
compani
last
five
year
sorger
lab
receiv
research
fund
novarti
merck
sorger
declar
none
relationship
directli
indirectli
relat
content
manuscript
nrb
consult
receiv
honoraria
follow
compani
seattl
genet
sanofi
bayer
author
affili
receiv
compens
tomi
environment
solut
inc
tomi
play
role
design
studi
author
correspond
member
tomi
corpor
concern
technic
specif
steramist
system
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
figur
illustr
photograph
handheld
devic
process
steril
environment
steramist
system
dupont
tyvek
coveral
figur
imag
ambient
particul
matter
air
duct
use
mit
test
mask
note
destruct
test
mask
cut
prior
introduct
test
chamber
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
